23 WiSys Technologies in "Pharmaceuticals & Vitamin D" or "Materials & Chemicals"
WiSys Technology Foundation is currently seeking a strategic industry partner to assist in the further development of its lead compound, A11, and related analogues providing a route to market for their use as novel skin whitening/lightening agents.The competitive advantage of these compounds over existing agents on the market is that they produce long-acting and reversible skin lightening with no toxicity.
WiSys is currently seeking strategic partners in the 3D printing and material supply industry that are interested in accessing and commercializing its patented process and associated recipes for refractory molds for the investment casting industry.
UW-Stevens Point researcher, John Droske, has developed a series of novel biodegradable polymers for use in the healthcare and plastics industry. WiSys is currently seeking a strategic partner to further development this technology and provide a route to market for its commercialization.
The WiSys Technology Foundation is seeking commercial partners interested in developing anxiolytic and anticonvulsant benzodiazepines that offer little or no side effects.